Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2011
05/10/2011US7939286 Luciferase assay buffer comprising: coelenterazine and sodium chloride for use as tool in monitoring bioluminescence in biological tissues
05/10/2011US7939285 Filtration method for detecting microbial contamination
05/10/2011US7939284 Methods using O6-alkylguanine-DNA alkyltransferases
05/10/2011US7939280 Marker for inflammatory conditions
05/10/2011US7939279 Mammalian T1R3 sweet taste receptors
05/10/2011US7939278 Methods and compositions for risk stratification
05/10/2011US7939274 Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms
05/10/2011US7939271 Using tumor antigen profiles as evalauative tool monitoring efficacy of antitumor therapeujtic agents
05/10/2011US7939264 DNA sequencing method
05/10/2011US7939263 Compositions and methods for treating and diagnosing cancer
05/10/2011US7939262 Method for the diagnosis of schizophrenia
05/10/2011US7939261 Expression profile algorithm and test for cancer prognosis
05/10/2011US7939260 Method for making available a priming oligonucleotide
05/10/2011US7939259 High throughput nucleic acid sequencing by expansion
05/10/2011US7939258 Nucleic acid amplification procedure using RNA and DNA composite primers
05/10/2011US7939257 Polymorphic GHSR nucleic acids and uses thereof
05/10/2011US7939256 Composition and method for nucleic acid sequencing
05/10/2011US7939255 Using comparative genomic hybridization (CGH) as evaluative tool in screening recurrently altered regions (RAR) along chromosomes which are associated with cell proliferative disorders
05/10/2011US7939254 Breast cancer related gene ZNFN3A1
05/10/2011US7939253 detecting in a test sample to be analyzed for Ewing's sarcoma, expression of NKX2.2; (comparing the expression of NKX2.2 in the test sample to the expression of NKX2.2 in a control, (cells where Ewing's sarcoma iabsent); histone deacetylase inhibitor is suberoylanilide hydroxamic acid or Trichostatin A
05/10/2011US7939252 Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence
05/10/2011US7939251 SENP1 as a marker for cancer
05/10/2011US7939250 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
05/10/2011US7939249 separation and purification of deoxyribonucleic acids, ribonucleic acids or peptide nucleic acids, from biological samples such as blood or tissues
05/10/2011US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration
05/10/2011US7939082 Papilloma virus vaccine
05/10/2011US7939071 Artery- and vein-specific proteins and uses therefor
05/10/2011US7939061 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
05/10/2011US7939018 Multi-format sample processing devices and systems
05/10/2011CA2498352C A method for the identification of drug targets
05/10/2011CA2483105C Autoimmune conditions and nadph oxidase defects
05/10/2011CA2478016C Presynaptic protein p120
05/10/2011CA2464987C Aequorin as a reporter gene in yeast
05/10/2011CA2458811C Selection of cells expressing heteromeric polypeptides
05/10/2011CA2455805C Compounds and methods for therapeutic intervention in preventing diabetic complications
05/10/2011CA2451378C Assay for measuring factor viia-antithrombin complexes
05/10/2011CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
05/10/2011CA2417104C Use of monodispersed polymer particles for measuring the adhesivity of platelets in vivo
05/10/2011CA2415460C Widely applicable process for identifying modulators of g-protien-coupled receptors
05/10/2011CA2411056C Pharmaceutical compositions containing prostacyclin synthase gene
05/10/2011CA2401852C Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster
05/10/2011CA2392435C An isolated plant gene encoding a .beta.-amyrin synthase
05/10/2011CA2388272C Electrochemical test strip for use in analyte determination
05/10/2011CA2375605C Peptide leukotriene receptor
05/10/2011CA2361249C Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
05/10/2011CA2344590C Treatment of inflammatory disease
05/10/2011CA2323812C Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins)
05/10/2011CA2318789C Cellular arrays for rapid molecular profiling
05/10/2011CA2314996C Carbohydrate oxidase and use thereof in baking
05/10/2011CA2311479C Procedure for the determination of the activity of the protease which activates factor vii from protein solutions
05/10/2011CA2306441C Peptides derived from the env gene of the feline immunodeficiency virus and their applications
05/10/2011CA2292898C Bacterial pheromones and uses therefor
05/10/2011CA2283758C Spinocerebellar ataxia type 8 and methods of detection
05/10/2011CA2283375C Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity
05/10/2011CA2248016C Direct molecular diagnosis of friedreich ataxia
05/10/2011CA2200627C Method for amplifying nucleic acid sequences by translocation using chimeric primers
05/10/2011CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use
05/05/2011WO2011054011A2 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
05/05/2011WO2011053987A1 Compositions and methods for targeted nucleic acid sequence selection and amplification
05/05/2011WO2011053944A2 Gfp mutagenesis amplification: use of a flourescence-antibiotic resistance fusion dual reporter construct to provide quantitative and highly sensitive detection of mutations
05/05/2011WO2011053907A2 Human omental mesothelial cells, methods of isolation and uses thereof
05/05/2011WO2011053894A2 Methods and apparatus for binding assays
05/05/2011WO2011053871A2 Multi-primer assay for mycoplasma detection
05/05/2011WO2011053864A2 Bacterial metastructure and methods of use
05/05/2011WO2011053854A1 Use of methylsulfonylmethane (msm) to modulate microbial activity
05/05/2011WO2011053852A1 Gna11 mutations in melanoma
05/05/2011WO2011053845A2 Microvessels, microparticles, and methods of manufacturing and using the same
05/05/2011WO2011053831A1 Methods for diagnosing irritable bowel syndrome
05/05/2011WO2011053825A2 Compositions and methods for the treatment or prevention of mitochondrial diseases
05/05/2011WO2011053790A2 Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis
05/05/2011WO2011053779A2 Methods for treating cancer in patients having igf-1r inhibitor resistance
05/05/2011WO2011053774A1 Single nucleotide polymorphisms and genes associated with age-related macular degeneration
05/05/2011WO2011053727A2 Methods and systems for reducing dna fragmentation in a population of sperm cells
05/05/2011WO2011053715A2 Analyte sensor layers and methods
05/05/2011WO2011053666A1 Method of predicting risk of preterm birth
05/05/2011WO2011053430A1 A novel method to generate bioactive compounds in algae
05/05/2011WO2011053257A2 Methods of monitoring cellular states
05/05/2011WO2011053241A1 Multiplex detection
05/05/2011WO2011053134A2 Determination of genetic risk for ventricular fibrillation
05/05/2011WO2011052906A2 Use of eif3m for the diagnosis and treatment of cancer
05/05/2011WO2011052755A1 Probe for detecting mpl gene polymorphism and use of the same
05/05/2011WO2011052754A1 Probe for detecting polymorphism in egfr genes, and usage therefor
05/05/2011WO2011052752A1 Device comprising foldable structural object
05/05/2011WO2011052592A1 Method for evaluating risk of inducing onset of atopic dermatitis by breast milk or food or drink, and breast milk or food or drink with reduced risk of inducing onset of atopic dermatitis
05/05/2011WO2011052586A1 Method for detection of target nucleic acid
05/05/2011WO2011052550A1 METHOD FOR MEASURING CHOLESTEROL IN ApoE-CONTAINING HDL
05/05/2011WO2011052244A1 A method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
05/05/2011WO2011052013A1 Nucleic acid strand binding method and nucleic acid strand modification method
05/05/2011WO2011051774A1 Apparatus for blocking nucleic acids by means of photoactivating intercalating agents
05/05/2011WO2011051709A1 A proximity ligation assay involving generation of catalytic activity
05/05/2011WO2011051495A1 Determination of 17q gain in neuroblastoma patients by analysis of circulating dna
05/05/2011WO2011051471A1 Circulating mirnas as non-invasive markers for diagnosis and staging in prostate cancer
05/05/2011WO2011051414A1 Method for the prognosis of ovarian carcinoma
05/05/2011WO2011051402A1 New biomarkers for determining allergy status
05/05/2011WO2011051283A1 Means and methods for non-invasive diagnosis of chromosomal aneuploidy
05/05/2011WO2011051278A1 Lung tumor markers and methods of use thereof
05/05/2011WO2011051120A1 Tomato fruit having increased firmness
05/05/2011WO2011050981A2 Method for detecting balanced chromosomal aberrations in a genome
05/05/2011WO2011050938A1 Conjugates of nucleotides and method for the application thereof
05/05/2011WO2011050672A1 In-vitro cultivation model of hepatitis virus, construction method and applications thereof